He completed his undergraduate studies in Physiology at the University of Saskatchewan, and subsequently pursued his Master’s and PhD degrees at Queen’s University. After a fellowship in Cardiac Surgery and Regenerative Medicine at Toronto General Hospital, he became an Assistant Professor in Pharmacology and Medicine in Saint John. Dr Brunt is the Chief Scientific Officer at NB-BioMatrix, Inc., and is also a special graduate faculty member at the University of Guelph in Ontario. His research interests include molecular and cellular cardiology, nano-pharmocology and heme metabolism.